FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ullrich Wüllner

Research Profile

Disorders

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
K Srulijes; Gregor Wenning; Ullrich Wüllner; R Asselta; P Barone; Daniela Berg; K Brockmann; Roberto Cilia; S Goldwurm; I Guella; A-K Hauser; Walter Maetzler; Wolfgang H Oertel; Werner Poewe; L Schols; C Schulte; Giulia Soldà; Thomas Gasser
No association of GBA mutations and multiple system atrophy.
Jeannette Hübener; Fabronia Murad; Peter Bellstedt; Peter Breuer; Lisa Honold; Francois Paquet-Durand; Claudia Richter; Olaf Riess; Takaomi C Saido; Jiro Takano; Jonasz Jeremiasz Weber; Andreas Weiss; Ullrich Wüllner; Huu-Phuc Nguyen
Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3).
Ina Schmitt; Jan Pierre van Rooyen; Alexander Volk; Ullrich Wüllner; Julian Becker; Tim Becker; Hassan Khazneh; Christine Klein; Vladimir S Kostic; Christian Kubisch; Alfredo Ramirez
Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ullrich Wüllner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: K Srulijes; Gregor Wenning; Ullrich Wüllner; R Asselta; P Barone; Daniela Berg; K Brockmann; Roberto Cilia; S Goldwurm; I Guella; A-K Hauser; Walter Maetzler; Wolfgang H Oertel; Werner Poewe; L Schols; C Schulte; Giulia Soldà; Thomas Gasser
No association of GBA mutations and multiple system atrophy.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2013;20(4):e61-2.
2013: Jeannette Hübener; Fabronia Murad; Peter Bellstedt; Peter Breuer; Lisa Honold; Francois Paquet-Durand; Claudia Richter; Olaf Riess; Takaomi C Saido; Jiro Takano; Jonasz Jeremiasz Weber; Andreas Weiss; Ullrich Wüllner; Huu-Phuc Nguyen
Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3).
Human molecular genetics 2013;22(3):508-18.
2012: Ina Schmitt; Jan Pierre van Rooyen; Alexander Volk; Ullrich Wüllner; Julian Becker; Tim Becker; Hassan Khazneh; Christine Klein; Vladimir S Kostic; Christian Kubisch; Alfredo Ramirez
Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression.
European journal of human genetics : EJHG 2012;20(12):1265-9.
2012: Ullrich Wüllner; Gerd Fuchs; Olaf Randerath; Nicole Reketat; Jan Kassubek
Requirements for Parkinson's disease pharmacotherapy from the patients' perspective: a questionnaire-based survey.
Current medical research and opinion 2012;28(7):1239-46.
2012: M Möhlenbruch; M Nelles; Thorsten Okulla; Hans H Schild; M Seifert; Susanne Greschus; Dariusch R Hadizadeh; Thomas Klockgether; K Wilhelm; Ullrich Wüllner; Horst Urbach
Mechanical thrombectomy compared to local-intraarterial thrombolysis in carotid T and middle cerebral artery occlusions: a single center experience.
Clinical neuroradiology 2012;22(2):141-7.
2012: Jan Bucerius; Zahi A Fayad; Daniela Gündisch; Venkatesh Mani; Christoph Manka; Felix M Mottaghy; James Rudd; Joern Schmaljohann; Ullrich Wüllner; Rolf Bippus; Hans-Jürgen Biersack
Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo.
JACC. Cardiovascular imaging 2012;5(5):528-36.
2012: Oliver Kaut; Ina Schmitt; Ullrich Wüllner
Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1.
Neurogenetics 2012;13(1):87-91.
2012: Michael Linnebank; Wolfgang Maier; Susanna Moskau; Christian G Schütz; Alexander Semmler; Gisela Bopp; Barbara Hoefgen; Ulf Kallweit; Ullrich Wüllner
A possible genetic link between MTHFR genotype and smoking behavior.
PloS one 2012;7(12):e53322.
2012: Matthias K Weng; Ullrich Wüllner; Bastian Zimmer; Dominik Pöltl; Agapios Sachinidis; Tanja Waldmann; Marc P Broeg; John A Gaspar; Violeta Ivanova; Marcel Leist
Extensive transcriptional regulation of chromatin modifiers during human neurodevelopment.
PloS one 2012;7(5):e36708.
2011: Julieta Araujo; Peter Breuer; Susanne Dieringer; Stephanie Dorn; Thomas Klockgether; Sybille Krauss; Alexander Pfeifer; Ullrich Wüllner; Katrin Zimmermann; Bernd Evert
FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3.
Human molecular genetics 2011;20(15):2928-41.
2011: Sathish Kumar; Nasrollah Rezaei-Ghaleh; Dick Terwel; Dietmar R Thal; Mélisande Richard; Michael Hoch; Jessica M Mc Donald; Ullrich Wüllner; Konstantin Glebov; Michael T Heneka; Dominic M Walsh; Markus Zweckstetter; Jochen Walter
Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease.
The EMBO journal 2011;30(11):2255-65.
2011: Matthis Synofzik; Christian Beetz; Claudia Bauer; Michael Bonin; Elena Sanchez-Ferrero; Tanja Schmitz-Hübsch; Ullrich Wüllner; Thomas Nägele; Olaf Riess; Ludger Schöls; Peter Bauer
Spinocerebellar ataxia type 15: diagnostic assessment, frequency, and phenotypic features.
Journal of medical genetics 2011;48(6):407-12.
2011: Johannes Schwarz; P Odin; C Buhmann; I Csoti; W Jost; Ullrich Wüllner; Alexander Storch
Depression in Parkinson's disease.
Journal of neurology 2011;258(Suppl 2):S336-8.
2011: Oliver Kaut; Martina Minnerop; Sebastian Paus; Niels Allert; Christoph Coch; Agata Grzeska; Ullrich Wüllner
Stochastic resonance therapy in Parkinson's disease.
NeuroRehabilitation 2011;28(4):353-8.
2010: Martina Minnerop; Eileen Lüders; Karsten Specht; Jürgen Ruhlmann; Nicole Schimke; Paul M Thompson; Yi Y Chou; Arthur W Toga; Michael Abele; Ullrich Wüllner; Thomas Klockgether
Callosal tissue loss in multiple system atrophy--a one-year follow-up study.
Movement disorders : official journal of the Movement Disorder Society 2010;25(15):2613-20.
2010: Peter Bauer; Giovanni Stevanin; Christian Beetz; Matthis Synofzik; Tanja Schmitz-Hübsch; Ullrich Wüllner; Eric Berthier; Elisabeth Ollagnon-Roman; Olaf Riess; Sylvie Forlani; Emeline Mundwiller; Alexandra Durr; Ludger Schöls; Alexis Brice
Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindreds.
Journal of neurology, neurosurgery, and psychiatry 2010;81(11):1229-32.
2010: Bin Zheng; Zhixiang Liao; Joseph J Locascio; Kristen A Lesniak; Sarah S Roderick; Marla L Watt; Aron C Eklund; Yanli Zhang-James; Peter D Kim; Michael A Hauser; Edna Grünblatt; Linda B Moran; Silvia A Mandel; Peter Riederer; Renee M Miller; Howard Federoff; Ullrich Wüllner; Spyridon Papapetropoulos; Moussa B Youdim; Ippolita Cantuti-Castelvetri; Anne B Young; Jeffery Vance; Richard L Davis; John C Hedreen; Charles H Adler; Thomas Beach; Manuel B Graeber; Frank A Middleton; Jean-Christophe Rochet; Clemens R Scherzer
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.
Science translational medicine 2010;2(52):52ra73.
2010: Ina Klinke; Martina Minnerop; Tanja Schmitz-Hübsch; Marc Hendriks; Thomas Klockgether; Ullrich Wüllner; Christoph Helmstaedter
Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.
Cerebellum (London, England) 2010;9(3):433-42.
2010: Ullrich Wüllner; Jan Kassubek; Per Odin; Michael Schwarz; Markus Naumann; Hermann-Josef Häck; Babak Boroojerdi; Heinz Reichmann
Transdermal rotigotine for the perioperative management of Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2010;117(7):855-9.
2010: Sebastian Paus; F Gadow; O Kaut; Michael Knapp; Christine Klein; Thomas Klockgether; Ullrich Wüllner
Tremor in Parkinson's disease is not associated with the DRD3 Ser9Gly polymorphism.
Parkinsonism & related disorders 2010;16(6):381-3.
2010: Ahmad Jowaed; Ina Schmitt; Oliver Kaut; Ullrich Wüllner
Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(18):6355-9.
2010: Peter Breuer; Annette Haacke; Bernd Evert; Ullrich Wüllner
Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control.
The Journal of biological chemistry 2010;285(9):6532-7.
2010: Thomas Hummel; Klaus Fliessbach; Michael Abele; Thorsten Okulla; Jens Reden; Heinz Reichmann; Ullrich Wüllner; Antje Haehner
Olfactory FMRI in patients with Parkinson's disease.
Frontiers in integrative neuroscience 2010;4():125.
2010: Alexander Kurz; Kay L Double; Isabel Lastres-Becker; Alessandro Tozzi; Michela Tantucci; Vanessa Bockhart; Michael Bonin; Moisés García-Arencibia; Silke Nuber; Falk Schlaudraff; Birgit Liss; Javier Fernández-Ruiz; Manfred Gerlach; Ullrich Wüllner; Hartmut Lüddens; Paolo Calabresi; Georg Auburger; Suzana Gispert
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.
PloS one 2010;5(7):e11464.
2009: Thorsten Mueller; Peter Breuer; Ina Schmitt; Jochen Walter; Bernd Evert; Ullrich Wüllner
CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3.
Human molecular genetics 2009;18(17):3334-43.
2009: Sebastian Paus; Franziska Gadow; Michael Knapp; Christine Klein; Thomas Klockgether; Ullrich Wüllner
Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism.
Movement disorders : official journal of the Movement Disorder Society 2009;24(7):1080-4.
2009: Marcus C Mueller; Ulf Jüptner; Ullrich Wüllner; Stefan Wirz; Andreas Türler; Andreas Hirner; Jens Standop
Parkinson's disease influences the perioperative risk profile in surgery.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2009;394(3):511-5.
2009: Julia Fuchs; Jakob C Mueller; Peter Lichtner; Claudia Schulte; Marita Munz; Daniela Berg; Ullrich Wüllner; Thomas Illig; Manu Sharma; Thomas Gasser
The transcription factor PITX3 is associated with sporadic Parkinson's disease.
Neurobiology of aging 2009;30(5):731-8.
2009: Julius Popp; Karsten Schaper; Heike Kölsch; Gabriela Cvetanovska; Fatima Rommel; Dietrich Klingmüller; Richard Dodel; Ullrich Wüllner; Frank Jessen
CSF cortisol in Alzheimer's disease and mild cognitive impairment.
Neurobiology of aging 2009;30(3):498-500.
2009: Aleksandar Rakovic; Barbara Stiller; Ana Djarmati; Antonia Flaquer; Jan Freudenberg; Mohammad-Reza Toliat; Michael Linnebank; Vladimir Kostic; Katja Lohmann; Sebastian Paus; Peter Nürnberg; Christian Kubisch; Christine Klein; Ullrich Wüllner; Alfredo Ramirez
Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(3):429-33.
2009: Martina Minnerop; Karsten Specht; Jürgen Ruhlmann; Christoph Grothe; Ullrich Wüllner; Thomas Klockgether
In vivo voxel-based relaxometry in amyotrophic lateral sclerosis.
Journal of neurology 2009;256(1):28-34.
2008: Heike C Pieper; Bernd Evert; Oliver Kaut; Peter Riederer; Andreas Waha; Ullrich Wüllner
Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability.
Neurobiology of disease 2008;32(3):521-7.
2008: Martina Minnerop; Martin Herbst; Rolf Fimmers; Bertfried Matz; Thomas Klockgether; Pavlina Kaabar; Ullrich Wüllner
Bell's palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone.
Journal of neurology 2008;255(11):1726-30.
2008: M Nelles; Wolfgang Block; Frank Träber; Ullrich Wüllner; Hans H Schild; Horst Urbach
Combined 3T diffusion tensor tractography and 1H-MR spectroscopy in motor neuron disease.
AJNR. American journal of neuroradiology 2008;29(9):1708-14.
2008: Saskia Biskup; Manfred Gerlach; Andreas Kupsch; Heinz Reichmann; Peter Riederer; Peter Vieregge; Ullrich Wüllner; Thomas Gasser
Genes associated with Parkinson syndrome.
Journal of neurology 2008;255 Suppl 5():8-17.
2008: Sebastian Paus; Anne Grünewald; Christine Klein; Michael Knapp; Alexander Zimprich; Bernd Janetzky; J Carsten Möller; Thomas Klockgether; Ullrich Wüllner
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23(4):599-602.
2008: M C Müller; U Jüptner; Ullrich Wüllner; Stefan Wirz; Andreas Türler; D C Wirtz; Andreas Hirner; Jens Standop
[Parkinson's disease influences the perioperative risk profile in trauma patients].
Zeitschrift für Orthopädie und Unfallchirurgie 2008;146(2):227-30.
2008: Ullrich Wüllner; Daniela Gündisch; Hans Herzog; Martina Minnerop; Alexius Y Joe; Marc Warnecke; Frank Jessen; Christian Schütz; Michael Reinhardt; Wolfgang Eschner; Thomas Klockgether; Joern Schmaljohann
Smoking upregulates alpha4beta2* nicotinic acetylcholine receptors in the human brain.
Neuroscience letters 2008;430(1):34-7.
2007: Ullrich Wüllner; Tanja Schmitz-Hübsch; Gisela Antony; Rolf Fimmers; A Spottke; Wolfgang H Oertel; Günther Deuschl; Thomas Klockgether; Karla Eggert
Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(12):1405-8.
2007: Ina Schmitt; Marion Linden; Hassan Khazneh; Bernd Evert; Peter Breuer; Thomas Klockgether; Ullrich Wüllner
Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination.
Biochemical and biophysical research communications 2007;362(3):734-9.
2007: Ullrich Wüllner; Tanja Schmitz-Hübsch; Michael Abele; Gisela Antony; Peter Bauer; Karla Eggert
Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(9):1161-5.
2007: Jan Seyfried; Ullrich Wüllner
Inhibition of thioredoxin reductase induces apoptosis in neuronal cell lines: role of glutathione and the MKK4/JNK pathway.
Biochemical and biophysical research communications 2007;359(3):759-64.
2007: Sebastian Paus; Tanja Schmitz-Hübsch; Ullrich Wüllner; Antje Vogel; Thomas Klockgether; Michael Abele
Bright light therapy in Parkinson's disease: a pilot study.
Movement disorders : official journal of the Movement Disorder Society 2007;22(10):1495-8.
2007: Martina Minnerop; Karsten Specht; Jürgen Ruhlmann; N Schimke; Michael Abele; Anja Weyer; Ullrich Wüllner; Thomas Klockgether
Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters.
NeuroImage 2007;36(4):1086-95.
2007: Susanna Moskau; Susan Farmand; Alexander Semmler; Ullrich Wüllner; Christoph Pohl; Thomas Klockgether; Michael Linnebank
The methionine synthase polymorphism c.2756A>G (D919G) influences diastolic blood pressure.
Journal of human hypertension 2007;21(5):418-20.
2007: Karla Eggert; Ullrich Wüllner; Gisela Antony; Thomas Gasser; Bernd Janetzky; Christine Klein; Ludger Schöls; Wolfgang H Oertel
Data protection in biomaterial banks for Parkinson's disease research: the model of GEPARD (Gene Bank Parkinson's Disease Germany).
Movement disorders : official journal of the Movement Disorder Society 2007;22(5):611-8.
2007: Marianne Patt; Christoph Solbach; Ullrich Wüllner; A Blocher; Anke Stahlschmidt; Daniela Gündisch; Karl-Artur Kovar; Hans-Jürgen Machulla
Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2007;10(2):312s-320s.
2006: Bernd Evert; J Schelhaas; H Fleischer; Rob A I de Vos; Ewout R Brunt; W Stenzel; Thomas Klockgether; Ullrich Wüllner
Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3.
Clinical neuropathology 2006;25(6):272-81.
2006: Bernd Evert; Julieta Araujo; Ana M Vieira-Saecker; Rob A I de Vos; Sigrid Harendza; Thomas Klockgether; Ullrich Wüllner
Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(44):11474-86.
2006: Michael Linnebank; Susanna Moskau; Susan Farmand; Klaus Fliessbach; Heike Kölsch; Monika Bös; Christoph Grothe; Dietmar Becker; Ursula Harbrecht; Christoph Pohl; Ullrich Wüllner; Thomas Klockgether
Homocysteine and carotid intima-media thickness in a german population: lack of clinical relevance.
Stroke; a journal of cerebral circulation 2006;37(11):2840-2.
2006: Ina Schmitt; Ullrich Wüllner; Daniel G Healy; Nicholas W Wood; Heike Kölsch; Reinhard Heun
The ADH1C stop mutation in multiple system atrophy patients and healthy probands in the United Kingdom and Germany.
Movement disorders : official journal of the Movement Disorder Society 2006;21(11):2034.
2006: Michael Linnebank; Alexander Semmler; Wim J Kleijer; Marianne L T van der Sterre; Jutta Gärtner; Klaus Fliessbach; Piotr Sokolowski; Wolfgang Köhler; Uwe Schlegel; Thomas Klockgether; Ronald J A Wanders; Stephan Schmidt; Ullrich Wüllner; Stephan Kemp
The cystathionine beta-synthase variant c.844_845ins68 protects against CNS demyelination in X-linked adrenoleukodystrophy.
Human mutation 2006;27(10):1063-4.
2006: Michael Linnebank; Holger Lutz; Eva Jarre; Stefan Vielhaber; Carmen Noelker; Eduard Struys; Cornelis Jakobs; Thomas Klockgether; Bernd Evert; Wolfram S Kunz; Ullrich Wüllner
Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY-5Y cells.
Neurobiology of disease 2006;23(3):725-30.
2006: Monika Jeub; Martin Herbst; Alexander Spauschus; Henrik Fleischer; Thomas Klockgether; Ullrich Wüllner; Bernd Evert
Potassium channel dysfunction and depolarized resting membrane potential in a cell model of SCA3.
Experimental neurology 2006;201(1):182-92.
2006: Ina R Vogt; Andrew J Lees; Bernd Evert; Thomas Klockgether; Michael Bonin; Ullrich Wüllner
Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.
Experimental neurology 2006;199(2):465-78.
2006: Christian Rabe; Z Balta; Ullrich Wüllner; J Heller; Christoph Hammerstingl; Klaus Tiemann; Torsten Sommer; Michael Schepke; Hans-Peter Fischer; Tilman Sauerbruch
Biliary metal stents and air embolism: a note of caution.
Endoscopy 2006;38(6):648-50.
2006: Annett Boeddrich; Sébastien Gaumer; Annette Haacke; Nikolay Tzvetkov; Mario Albrecht; Bernd Evert; Eva-Christina Müller; Rudi Lurz; Peter Breuer; Nancy Schugardt; Stephanie Plassmann; Kexiang Xu; John M Warrick; Jaana Suopanki; Ullrich Wüllner; Ronald Frank; Ulrich F Hartl; Nancy M Bonini; Erich E Wanker
An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis.
The EMBO journal 2006;25(7):1547-58.
2006: Joern Schmaljohann; Daniela Gündisch; Martina Minnerop; Jan Bucerius; Alexius Y Joe; Michael Reinhardt; Stefan Guhlke; Hans-Jürgen Biersack; Ullrich Wüllner
In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease.
Nuclear medicine and biology 2006;33(3):305-9.
2006: Tetsutaro Ozawa; Daniel G Healy; Patrick M Abou-Sleiman; Kourosh R Ahmadi; Niall Quinn; Andrew J Lees; K Shaw; Ullrich Wüllner; J Berciano; J Carsten Moller; Christoph Kamm; Katrin Burk; Keith A Josephs; Paolo Barone; Eduardo Tolosa; David B Goldstein; Gregor Wenning; Felix Geser; Janice L Holton; Thomas Gasser; Tamas Revesz; Nicholas W Wood
The alpha-synuclein gene in multiple system atrophy.
Journal of neurology, neurosurgery, and psychiatry 2006;77(4):464-7.
2006: Tanja Schmitz-Hübsch; Derek Pyfer; Karin Kielwein; Rolf Fimmers; Thomas Klockgether; Ullrich Wüllner
Qigong exercise for the symptoms of Parkinson's disease: a randomized, controlled pilot study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(4):543-8.
2006: Michael Linnebank; Stephan Kemp; R J A Wanders; Wim J Kleijer; Marianne L T van der Sterre; J Gärtner; Klaus Fliessbach; Alexander Semmler; Piotr Sokolowski; Wolfgang Köhler; Uwe Schlegel; Stephan Schmidt; Thomas Klockgether; Ullrich Wüllner
Methionine metabolism and phenotypic variability in X-linked adrenoleukodystrophy.
Neurology 2006;66(3):442-3.
2006: Jan Bucerius; Alexius Y Joe; Joern Schmaljohann; Daniela Gündisch; Martina Minnerop; Hans-Jürgen Biersack; Ullrich Wüllner; Michael Reinhardt
Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo.
Clinical research in cardiology : official journal of the German Cardiac Society 2006;95(2):105-9.
2006: Zdenek Berger; Brinda Ravikumar; Fiona M Menzies; Lourdes Garcia Oroz; Benjamin R Underwood; Menelas Pangalos; Ina Schmitt; Ullrich Wüllner; Bernd Evert; Cahir J O'Kane; David C Rubinsztein
Rapamycin alleviates toxicity of different aggregate-prone proteins.
Human molecular genetics 2006;15(3):433-42.
2006: S Breit; Matthias Reimold; Gerald Reischl; Thomas Klockgether; Ullrich Wüllner
[(11)C]d-threo-methylphenidate PET in patients with Parkinson's disease and essential tremor.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(2):187-93.
2005: Ullrich Wüllner; Heike Kölsch; Michael Linnebank
Methylenetetrahydrofolate reductase in Parkinson's disease.
Annals of neurology 2005;58(6):972-3.
2005: Saskia Biskup; Jakob C Mueller; Manu Sharma; Peter Lichtner; Alexander Zimprich; Daniela Berg; Ullrich Wüllner; Thomas Illig; Thomas Meitinger; Thomas Gasser
Common variants of LRRK2 are not associated with sporadic Parkinson's disease.
Annals of neurology 2005;58(6):905-8.
2005: Stephan Klebe; Alexandra Durr; Alexander Rentschler; Valerie Hahn-Barma; Michael Abele; Naima Bouslam; Ludger Schöls; Pierre Jedynak; Sylvie Forlani; Elodie Denis; Christel Dussert; Yves Agid; Peter Bauer; Christoph Globas; Ullrich Wüllner; Alexis Brice; Olaf Riess; Giovanni Stevanin
New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14.
Annals of neurology 2005;58(5):720-9.
2005: Michael Linnebank; Klaus Fliessbach; Heike Kolsch; Marcella Rietschel; Ullrich Wüllner
The methionine synthase polymorphism c.2756Aright curved arrow G (D919G) is relevant for disease-free longevity.
International journal of molecular medicine 2005;16(4):759-61.
2005: Joern Schmaljohann; Daniela Gündisch; Martina Minnerop; Alexius Y Joe; Jan Bucerius; C Dittmar; F Jessen; Stefan Guhlke; Ullrich Wüllner
A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2005;63(4):433-5.
2005: Daniel G Healy; Patrick M Abou-Sleiman; Niall Quinn; Kourosh R Ahmadi; Tetsutaro Ozawa; Christoph Kamm; Ullrich Wüllner; Wolfgang H Oertel; Katrin Burk; Erik Dupont; Maria T Pellecchia; Eduardo Tolosa; Thomas Gasser; Janice L Holton; Tamas Revesz; David B Goldstein; Andrew J Lees; Nicholas W Wood
UCHL-1 gene in multiple system atrophy: a haplotype tagging approach.
Movement disorders : official journal of the Movement Disorder Society 2005;20(10):1338-43.
2005: Martina Minnerop; Alexius Y Joe; Martin Lutz; P Bauer; Horst Urbach; C Helmstaedter; Michael Reinhardt; Thomas Klockgether; Ullrich Wüllner
Putamen dopamine transporter and glucose metabolism are reduced in SCA17.
Annals of neurology 2005;58(3):490-1.
2005: Daniela Berg; Marc Niwar; Sylvia Maass; Alexander Zimprich; J Carsten Möller; Ullrich Wüllner; Tanja Schmitz-Hübsch; Christine Klein; Eng-King Tan; Ludger Schöls; Laura Marsh; Ted M Dawson; Bernd Janetzky; Thomas Müller; Dirk Woitalla; Vladimir Kostic; Peter P Pramstaller; Wolfgang H Oertel; Peter Bauer; Rejko Krueger; Thomas Gasser; Olaf Riess
Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.
Movement disorders : official journal of the Movement Disorder Society 2005;20(9):1191-4.
2005: Ullrich Wüllner; Matthias Reimold; Michael Abele; Katrin Bürk; Martina Minnerop; Bernd-Michael Dohmen; Hans-Jürgen Machulla; Roland Bares; Thomas Klockgether
Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.
Archives of neurology 2005;62(8):1280-5.
2005: Michael Linnebank; M Montenarh; Heike Kölsch; Anja Linnebank; K Schnez; D Schweichel; Christoph Pohl; Horst Urbach; Reinhard Heun; Ursula Harbrecht; Thomas Klockgether; Ullrich Wüllner
Common genetic variants of homocysteine metabolism in ischemic stroke: a case-control study.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12(8):614-8.
2005: Christoph Kamm; Daniel G Healy; Niall Quinn; Ullrich Wüllner; J Carsten Moller; L Schols; Felix Geser; Katrin Burk; A D Børglum; Maria T Pellecchia; Eduardo Tolosa; F del Sorbo; C Nilsson; O Bandmann; Manu Sharma; Petra Mayer; M Gasteiger; A Haworth; Tetsutaro Ozawa; Andrew J Lees; J Short; P Giunti; Elke Holinski-Feder; T Illig; H E Wichmann; Gregor Wenning; Nicholas W Wood; Thomas Gasser
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group.
Brain : a journal of neurology 2005;128(Pt 8):1855-60.
2005: Jakob C Mueller; Julia Fuchs; Anne Hofer; Alexander Zimprich; Peter Lichtner; Thomas Illig; Daniela Berg; Ullrich Wüllner; Thomas Meitinger; Thomas Gasser
Multiple regions of alpha-synuclein are associated with Parkinson's disease.
Annals of neurology 2005;57(4):535-41.
2005: Silvia Buervenich; Andrea Carmine; Dagmar Galter; Haydeh N Shahabi; Bo Johnels; Björn Holmberg; Jarl Ahlberg; Hans Nissbrandt; Johanna Eerola; Olli Hellström; Pentti J Tienari; Tohru Matsuura; Tetsuo Ashizawa; Ullrich Wüllner; Thomas Klockgether; Alexander Zimprich; Thomas Gasser; Melissa Hanson; Shamaila Waseem; Andrew Singleton; Francis McMajon; Maria Anvret; Olof Sydow; Lars Olson
A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample.
Archives of neurology 2005;62(1):74-8.
2005: Martina Minnerop; Cornelia Kornblum; Alexius Y Joe; K Tatsch; Wolfram S Kunz; Thomas Klockgether; Ullrich Wüllner; Michael Reinhardt
Dopamine transporter SPECT in patients with mitochondrial disorders.
Journal of neurology, neurosurgery, and psychiatry 2005;76(1):118-20.
2004: Heike Kölsch; Michael Linnebank; Dieter Lütjohann; Frank Jessen; Ullrich Wüllner; Ursula Harbrecht; Karin M Thelen; Markus Kreis; Frank Hentschel; A Schulz; Klaus Von Bergmann; Wolfgang Maier; Reinhard Heun
Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke.
Neurology 2004;63(12):2255-60.
2004: Joern Schmaljohann; Martina Minnerop; P Karwath; Daniela Gündisch; Peter Falkai; Stefan Guhlke; Ullrich Wüllner
Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2004;61(6):1235-40.
2004: Michael Linnebank; Anja Linnebank; Monika Jeub; Thomas Klockgether; Ullrich Wüllner; Heike Kölsch; Reinhard Heun; Hans Georg Koch; Terttu Suormala; Brian Fowler
Lack of genetic dispositions to hyperhomocysteinemia in Alzheimer disease.
American journal of medical genetics. Part A 2004;131(1):101-2.
2004: Mario Albrecht; Michael Golatta; Ullrich Wüllner; Thomas Lengauer
Structural and functional analysis of ataxin-2 and ataxin-3.
European journal of biochemistry / FEBS 2004;271(15):3155-70.
2004: Michael Abele; Thomas Klockgether; Ullrich Wüllner
Spectral analysis of heart rate variability in multiple system atrophy and unexplained sporadic ataxia.
Journal of neurology 2004;251(7):894-5.
2004: Sebastian Paus; Gert Seeger; H Michael Brecht; Jürgen Köster; Mahha El-Faddagh; Markus M Nöthen; Thomas Klockgether; Ullrich Wüllner
Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2004;19(6):705-7.
2004: Ullrich Wüllner; M Abele; T Schmitz-Huebsch; K Wilhelm; R Benecke; Günther Deuschl; T Klockgether
Probable multiple system atrophy in a German family.
Journal of neurology, neurosurgery, and psychiatry 2004;75(6):924-5.
2004: Peter-Andreas Löschmann; Carmen De Groote; Lance Smith; Ullrich Wüllner; Günther Fischer; John A Kemp; Peter Jenner; Thomas Klockgether
Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease.
Experimental neurology 2004;187(1):86-93.
2004: J Carsten Möller; Candan Depboylu; Heike Kölsch; Frank Lohmüller; Oliver Bandmann; Petra Gocke; Yansheng Du; Sebastian Paus; Ullrich Wüllner; Thomas Gasser; Wolfgang H Oertel; Thomas Klockgether; Richard Dodel
Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's disease.
Neuroscience letters 2004;359(3):195-7.
2004: Daniel G Healy; Patrick M Abou-Sleiman; Tetsutaro Ozawa; Andrew J Lees; Kailash Bhatia; Kourosh R Ahmadi; Ullrich Wüllner; Jose Berciano; J Carsten Moller; Christoph Kamm; Katrin Burk; Paolo Barone; Eduardo Tolosa; Niall Quinn; David B Goldstein; Nicholas W Wood; Paolo Barrone
A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease.
Annals of neurology 2004;55(3):443-6.
2004: P Bauer; Franco Laccone; Arndt Rolfs; Ullrich Wüllner; S Bösch; Hartmut Peters; S Liebscher; M Scheible; J T Epplen; Bernhard H F Weber; E Holinski-Feder; H Weirich-Schwaiger; Deborah J Morris-Rosendahl; J Andrich; Olaf Riess
Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype.
Journal of medical genetics 2004;41(3):230-2.
2003: Michael Linnebank; K Kesper; Monika Jeub; Horst Urbach; Ullrich Wüllner; Thomas Klockgether; S Schmidt
Hereditary elevation of angiotensin converting enzyme suggesting neurosarcoidosis.
Neurology 2003;61(12):1819-20.
2003: Ullrich Wüllner
Genes implicated in the pathogenesis of spinocerebellar ataxias.
Drugs of today (Barcelona, Spain : 1998) 2003;39(12):927-37.
2003: Michael Abele; Alexander Riet; Thomas Hummel; Thomas Klockgether; Ullrich Wüllner
Olfactory dysfunction in cerebellar ataxia and multiple system atrophy.
Journal of neurology 2003;250(12):1453-5.
2003: Bernd Evert; Ina R Vogt; Ana M Vieira-Saecker; Lucia Ozimek; Rob A I de Vos; Ewout R Brunt; Thomas Klockgether; Ullrich Wüllner
Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3.
Journal of neuropathology and experimental neurology 2003;62(10):1006-18.
2003: Karsten Specht; Martina Minnerop; Michael Abele; Jürgen Reul; Ullrich Wüllner; Thomas Klockgether
In vivo voxel-based morphometry in multiple system atrophy of the cerebellar type.
Archives of neurology 2003;60(10):1431-5.
2003: Ina Schmitt; Bernd Evert; Hassan Khazneh; Thomas Klockgether; Ullrich Wüllner
The human MJD gene: genomic structure and functional characterization of the promoter region.
Gene 2003;314():81-8.
2003: Jan Seyfried; Bernd Evert; Cordelia S Schwarz; Matthias Schaupp; Jörg B Schulz; Thomas Klockgether; Ullrich Wüllner
Gene dosage-dependent effects of bcl-2 expression on cellular survival and redox status.
Free radical biology & medicine 2003;34(12):1517-30.
2003: Sebastian Paus; H Michael Brecht; Jürgen Köster; Gert Seeger; Thomas Klockgether; Ullrich Wüllner
Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2003;18(6):659-67.
2003: Ullrich Wüllner; Thomas Klockgether
Inflammation in Parkinson's disease.
Journal of neurology 2003;250 Suppl 1():I35-8.
2003: Mario Albrecht; Daniel Hoffmann; Bernd Evert; Ina Schmitt; Ullrich Wüllner; Thomas Lengauer
Structural modeling of ataxin-3 reveals distant homology to adaptins.
Proteins 2003;50(2):355-70.
2002: Cordelia S Schwarz; Jan Seyfried; Bernd Evert; Thomas Klockgether; Ullrich Wüllner
Bcl-2 up-regulates ha-ras mRNA expression and induces c-Jun phosphorylation at Ser73 via an ERK-dependent pathway in PC 12 cells.
Neuroreport 2002;13(18):2439-42.
2002: Wolfgang Wick; Jan Stock; Jan Seyfried; J Baumgart; Ullrich Wüllner; Michael Weller
CD95/CD95 ligand-independent potentiation of treosulfan cytotoxicity by BSO in malignant glioma cells in vitro and in vivo.
International journal of oncology 2002;21(1):213-20.
2001: D Fischer; Ullrich Wüllner; T Klockgether; R Schröder; K Wilhelm
Cervical spondylotic myopathy and Kennedy syndrome mimicking amyotrophic lateral sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2001;71(3):414.
2001: Bernd Evert; Ina R Vogt; C Kindermann; L Ozimek; Rob A I de Vos; Ewout R Brunt; Ina Schmitt; Thomas Klockgether; Ullrich Wüllner
Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(15):5389-96.
2001: Cordelia S Schwarz; Bernd Evert; Jan Seyfried; M Schaupp; Wolfram S Kunz; Stefan Vielhaber; Thomas Klockgether; Ullrich Wüllner
Overexpression of bcl-2 results in reduction of cytochrome c content and inhibition of complex I activity.
Biochemical and biophysical research communications 2001;280(4):1021-7.
2001: Sebastian Paus; Bernd Pötzsch; Jörn H Risse; Thomas Klockgether; Ullrich Wüllner
Chorea and antiphospholipid antibodies: treatment with methotrexate.
Neurology 2001;56(1):137-8.
2000: Jan Seyfried; Bernd Evert; C Rundfeldt; Jörg B Schulz; Karl-Artur Kovar; Thomas Klockgether; Ullrich Wüllner
Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells.
European journal of pharmacology 2000;400(2-3):155-66.
2000: Thomas Klockgether; Ullrich Wüllner; Alexander Spauschus; Bernd Evert
The molecular biology of the autosomal-dominant cerebellar ataxias.
Movement disorders : official journal of the Movement Disorder Society 2000;15(4):604-12.
2000: Bernd Evert; Ullrich Wüllner; Thomas Klockgether
Cell death in polyglutamine diseases.
Cell and tissue research 2000;301(1):189-204.
2000: Jan Seyfried; F Soldner; Wolfram S Kunz; Jörg B Schulz; Thomas Klockgether; Karl-Artur Kovar; Ullrich Wüllner
Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC 12 cells.
Neurochemistry international 2000;36(6):489-97.
2000: Michael T Heneka; L Dumitrescu; Peter-Andreas Löschmann; Ullrich Wüllner; Thomas Klockgether
Temporal, regional, and cell-specific changes of iNOS expression after intrastriatal microinjection of interferon gamma and bacterial lipopolysaccharide.
Journal of chemical neuroanatomy 2000;18(4):167-79.
2000: Ullrich Wüllner; M Weller; J Kornhuber; A Bornemann; Jörg B Schulz; Peter Riederer; Thomas Klockgether
Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cells.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):269-75.
2000: Sebastian Flacke; Ullrich Wüllner; Ewald Keller; F Hamzei; Horst Urbach
Reversible changes in echo planar perfusion- and diffusion-weighted MRI in status epilepticus.
Neuroradiology 2000;42(2):92-5.
1999: Michael T Heneka; Douglas L Feinstein; Elena Galea; Marc Gleichmann; Ullrich Wüllner; Thomas Klockgether
Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase.
Journal of neuroimmunology 1999;100(1-2):156-68.
1999: Carmen De Groote; Ullrich Wüllner; P A Löchmann; P G Luiten; Thomas Klockgether
Functional characterization and expression of thalamic GABA(B) receptors in a rodent model of Parkinson's disease.
Neuropharmacology 1999;38(11):1683-9.
1999: F Soldner; Michael Weller; S Haid; S Beinroth; S W Miller; Ullrich Wüllner; R E Davis; Johannes Dichgans; Thomas Klockgether; Jörg B Schulz
MPP+ inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1/Cip1).
Experimental cell research 1999;250(1):75-85.
1999: Bernd Evert; Ullrich Wüllner; Jörg B Schulz; M Weller; P Groscurth; Yvon Trottier; Alexis Brice; Thomas Klockgether
High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells.
Human molecular genetics 1999;8(7):1169-76.
1999: Ullrich Wüllner; Jan Seyfried; P Groscurth; S Beinroth; S Winter; Marc Gleichmann; Michael T Heneka; Peter-Andreas Löschmann; Jörg B Schulz; Michael Weller; Thomas Klockgether
Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function.
Brain research 1999;826(1):53-62.
1999: Jan Seyfried; F Soldner; Jörg B Schulz; Thomas Klockgether; Karl-Artur Kovar; Ullrich Wüllner
Differential effects of L-buthionine sulfoximine and ethacrynic acid on glutathione levels and mitochondrial function in PC12 cells.
Neuroscience letters 1999;264(1-3):1-4.
1999: Ullrich Wüllner; J Kornhuber; M Weller; Jörg B Schulz; Peter-Andreas Löschmann; Peter Riederer; Thomas Klockgether
Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note.
Acta neuropathologica 1999;97(4):408-12.
1998: Thomas Klockgether; Katrin Bürk; Ullrich Wüllner; Gregor Wenning; Jörg B Schulz; G Döller; Karl Wessel; P Huss; A Krämer; R Lüdtke
Risk factors for idiopathic cerebellar ataxia of late onset.
Journal of the neurological sciences 1998;160(2):171-4.
1998: Jörg B Schulz; Michael Weller; R T Matthews; Michael T Heneka; P Groscurth; J C Martinou; J Lommatzsch; R von Coelln; Ullrich Wüllner; Peter-Andreas Löschmann; M Flint Beal; Johannes Dichgans; Thomas Klockgether
Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia.
Cell death and differentiation 1998;5(10):847-57.
1998: Ullrich Wüllner; Stefan Isenmann; Marc Gleichmann; Thomas Klockgether; Mathias Bähr
Expression of neurotrophins and neurotrophin receptors in the cerebellum of mutant weaver and lurcher mice.
Brain research. Developmental brain research 1998;110(1):1-6.
1998: Ullrich Wüllner; Michael Weller; Jörg B Schulz; Stan Krajewski; JC Reed; Thomas Klockgether
Bcl-2, Bax and Bcl-x expression in neuronal apoptosis: a study of mutant weaver and lurcher mice.
Acta neuropathologica 1998;96(3):233-8.
1998: Michael T Heneka; Peter-Andreas Löschmann; Marc Gleichmann; Michael Weller; Jörg B Schulz; Ullrich Wüllner; Thomas Klockgether
Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide.
Journal of neurochemistry 1998;71(1):88-94.
1998: Jörg B Schulz; S Beinroth; Michael Weller; Ullrich Wüllner; Thomas Klockgether
Endonucleolytic DNA fragmentation is not required for apoptosis of cultured rat cerebellar granule neurons.
Neuroscience letters 1998;245(1):9-12.
1998: U Reber; Ullrich Wüllner; M Trepel; J Baumgart; Jan Seyfried; Thomas Klockgether; Johannes Dichgans; Michael Weller
Potentiation of treosulfan toxicity by the glutathione-depleting agent buthionine sulfoximine in human malignant glioma cells: the role of bcl-2.
Biochemical pharmacology 1998;55(3):349-59.
1998: Ullrich Wüllner; Bernd Evert; T Klockgether
Mechanisms of cell death in cerebellar disorders.
Restorative neurology and neuroscience 1998;13(1-2):69-73.
1998: Marc Gleichmann; S Beinroth; J C Reed; Stan Krajewski; Jörg B Schulz; Ullrich Wüllner; Thomas Klockgether; Michael Weller
Potassium deprivation-induced apoptosis of cerebellar granule neurons: cytochrome c release in the absence of altered expression of Bcl-2 family proteins.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 1998;8(4):194-201.
1997: Ullrich Wüllner; Michael Weller; P Groscurth; Peter-Andreas Löschmann; Jörg B Schulz; I Müller; Thomas Klockgether
Evidence for an active type of cell death with ultrastructural features distinct from apoptosis: the effects of 3-acetylpyridine neurotoxicity.
Neuroscience 1997;81(3):721-34.
1997: Jörg B Schulz; D Bremen; J C Reed; J Lommatzsch; S Takayama; Ullrich Wüllner; Peter-Andreas Löschmann; Thomas Klockgether; Michael Weller
Cooperative interception of neuronal apoptosis by BCL-2 and BAG-1 expression: prevention of caspase activation and reduced production of reactive oxygen species.
Journal of neurochemistry 1997;69(5):2075-86.
1997: Ullrich Wüllner; David G Standaert; CM Testa; John B Penney; Anne B Young
Differential expression of kainate receptors in the basal ganglia of the developing and adult rat brain.
Brain research 1997;768(1-2):215-23.
1997: Peter-Andreas Löschmann; Ullrich Wüllner; Michael T Heneka; Jörg B Schulz; M Kunow; H Wachtel; Thomas Klockgether
Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
Synapse (New York, N.Y.) 1997;26(4):381-91.
1997: Michael Weller; Jörg B Schulz; Ullrich Wüllner; Peter-Andreas Löschmann; Thomas Klockgether; Johannes Dichgans
Developmental and genetic regulation of programmed neuronal death.
Journal of neural transmission. Supplementum 1997;50():115-23.
1996: Thomas Klockgether; Ullrich Wüllner; Joachim P Steinbach; V Petersen; L Turski; Peter-Andreas Löschmann
Effects of the antiparkinsonian drug budipine on central neurotransmitter systems.
European journal of pharmacology 1996;301(1-3):67-73.
1996: F Eblen; Peter-Andreas Löschmann; Ullrich Wüllner; L Turski; Thomas Klockgether
Effects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions.
European journal of pharmacology 1996;299(1-3):9-16.
1996: Ullrich Wüllner; Peter-Andreas Löschmann; Jörg B Schulz; A Schmid; Ralf Dringen; F Eblen; L Turski; Thomas Klockgether
Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones.
Neuroreport 1996;7(4):921-3.
1995: Ullrich Wüllner; Peter-Andreas Löschmann; M Weller; Thomas Klockgether
Apoptotic cell death in the cerebellum of mutant weaver and lurcher mice.
Neuroscience letters 1995;200(2):109-12.
1995: Peter-Andreas Löschmann; F Eblen; Ullrich Wüllner; H Wachtel; T Kockgether
Lamotrigine has no antiparkinsonian activity in rat models of Parkinson's disease.
European journal of pharmacology 1995;284(1-2):129-34.
1995: Peter-Andreas Löschmann; F Eblen; Ullrich Wüllner; Thomas Klockgether
NMDA-mediated toxicity to striatal neurons is not reversed by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase.
Journal of neural transmission. Supplementum 1995;46():87-95.
1994: Ullrich Wüllner; Anne B Young; John B Penney; M Flint Beal
3-Nitropropionic acid toxicity in the striatum.
Journal of neurochemistry 1994;63(5):1772-81.
1994: D M Frim; Ullrich Wüllner; M Flint Beal; Ole Isacson
Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum.
Experimental neurology 1994;128(2):172-80.
1994: Thomas Klockgether; Peter-Andreas Löschmann; Ullrich Wüllner
New medical and surgical treatments for Parkinson's disease.
Current opinion in neurology 1994;7(4):346-52.
1994: Ullrich Wüllner; David G Standaert; CM Testa; G Bernhard Landwehrmeyer; M V Catania; John B Penney; Anne B Young
Glutamate receptor expression in rat striatum: effect of deafferentation.
Brain research 1994;647(2):209-19.
1994: Ullrich Wüllner; CM Testa; M V Catania; Anne B Young; John B Penney
Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions.
Brain research 1994;645(1-2):98-102.
1994: Ullrich Wüllner; P Pakzaban; Anna-Liisa Brownell; Philippe Hantraye; L Burns; T Shoup; David R Elmaleh; A J Petto; Roger D Spealman; G L Brownell
Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT.
Experimental neurology 1994;126(2):305-9.
1994: Anna-Liisa Brownell; Philippe Hantraye; Ullrich Wüllner; Leena M Hamberg; T Shoup; David R Elmaleh; D M Frim; Bertha K Madras; G L Brownell; Bruce R Rosen
PET- and MRI-based assessment of glucose utilization, dopamine receptor binding, and hemodynamic changes after lesions to the caudate-putamen in primates.
Experimental neurology 1994;125(1):41-51.
1993: L H Burns; K Sato; Ullrich Wüllner; Ole Isacson
Intra-nigra infusion of AMPA attenuates dopamine-dependent rotation in the rat.
Neuroreport 1993;4(9):1075-8.
1993: Thomas Klockgether; S Chamberlain; Ullrich Wüllner; Michael Fetter; Helmut Dittmann; D Petersen; Johannes Dichgans
Late-onset Friedreich's ataxia. Molecular genetics, clinical neurophysiology, and magnetic resonance imaging.
Archives of neurology 1993;50(8):803-6.
1993: Ullrich Wüllner; E Brouillet; Ole Isacson; Anne B Young; John B Penney
Glutamate receptor binding sites in MPTP-treated mice.
Experimental neurology 1993;121(2):284-7.
1993: Ullrich Wüllner; Thomas Klockgether; D Petersen; T Naegele; Johannes Dichgans
Magnetic resonance imaging in hereditary and idiopathic ataxia.
Neurology 1993;43(2):318-25.
1993: Thomas Klockgether; Ullrich Wüllner; Johannes Dichgans; Wolfgang Grodd; Thomas Nägele; D Petersen; G Schroth; O Schmidt; K Voigt
Clinical and imaging correlations in inherited ataxias.
Advances in neurology 1993;61():77-96.
1993: Thomas Klockgether; G Döller; Ullrich Wüllner; D Petersen; Johannes Dichgans
Cerebellar encephalitis in adults.
Journal of neurology 1993;240(1):17-20.
1992: Ullrich Wüllner; Andreas Kupsch; G Arnold; P Renner; C Scheid; R Scheid; Wolfgang H Oertel; Thomas Klockgether
The competitive NMDA antagonist CGP40.116 enhances L-dopa response in MPTP-treated marmosets.
Neuropharmacology 1992;31(7):713-5.
1992: Philippe Hantraye; Anna-Liisa Brownell; David R Elmaleh; Roger D Spealman; Ullrich Wüllner; G L Brownell; Bertha K Madras; Ole Isacson
Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism.
Neuroreport 1992;3(3):265-8.
1990: Ullrich Wüllner; T Klockgether
Is the antispastic action of baclofen mediated by GABAB receptors? GABAB receptors and spasticity.
Trends in pharmacological sciences 1990;11(3):103.
1989: Ullrich Wüllner; T Klockgether; KH Sontag
Phaclofen antagonizes the depressant effect of baclofen on spinal reflex transmission in rats.
Brain research 1989;496(1-2):341-4.
1989: T Klockgether; M Schwarz; Ullrich Wüllner; L Turski; KH Sontag
Myorelaxant effect after intrathecal injection of antispastic drugs in rats.
Neuroscience letters 1989;97(1-2):221-6.
1987: Ullrich Wüllner; T Klockgether; M Schwarz; KH Sontag
Behavioral actions of baclofen in the rat ventromedial thalamic nucleus: antagonism by delta-aminovalerate.
Brain research 1987;422(1):129-36.